• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cyclosporine delays host immune response to antibody enzyme conjugate in ADEPT.

作者信息

Bagshawe K D, Sharma S K

机构信息

Department of Surgery, Charing Cross Hospital, London, England.

出版信息

Transplant Proc. 1996 Dec;28(6):3156-8.

PMID:8962223
Abstract
摘要

相似文献

1
Cyclosporine delays host immune response to antibody enzyme conjugate in ADEPT.环孢素可延缓抗体酶偶联物在抗体导向酶解前药疗法中的宿主免疫反应。
Transplant Proc. 1996 Dec;28(6):3156-8.
2
Effect of cyclosporine on immunogenicity of a bacterial enzyme carboxypeptidase G2 in ADEPT.
Transplant Proc. 1996 Dec;28(6):3154-5.
3
Antibody-directed enzyme prodrug therapy: efficacy and mechanism of action in colorectal carcinoma.抗体导向酶前药疗法：在结直肠癌中的疗效及作用机制
Clin Cancer Res. 2000 Mar;6(3):765-72.
4
Initial trial use of murine monoclonal antibodies as immunotherapeutic agents for gastrointestinal adenocarcinoma.鼠单克隆抗体作为胃肠道腺癌免疫治疗药物的初步试验应用。
Hybridoma. 1986 Jul;5 Suppl 1:S109-15.
5
Mechanisms of tumor growth inhibition.肿瘤生长抑制机制。
Hybridoma. 1986 Jul;5 Suppl 1:S59-64.
6
Antibody directed enzyme prodrug therapy (ADEPT): clinical report.抗体导向酶前药疗法（ADEPT）：临床报告。
Dis Markers. 1991 May-Aug;9(3-4):233-8.
7
A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours.一项针对晚期结直肠癌或其他产生癌胚抗原（CEA）肿瘤患者的抗体导向酶前药疗法（ADEPT）的I期试验。
Br J Cancer. 2002 Sep 9;87(6):600-7. doi: 10.1038/sj.bjc.6600517.
8
Enhancement of antibody-directed enzyme prodrug therapy in colorectal xenografts by an antivascular agent.一种抗血管生成剂增强结直肠癌异种移植瘤中抗体导向酶前药疗法的作用
Cancer Res. 1999 Aug 15;59(16):3998-4003.
9
A monoclonal antibody (B72.3) to adenocarcinoma of the colon and related tumors.一种针对结肠腺癌及相关肿瘤的单克隆抗体（B72.3）。
Prog Clin Biol Res. 1989;288:63-72.
10
[Treatment of colorectal cancer with monoclonal antibodies].[单克隆抗体治疗结直肠癌]
Ugeskr Laeger. 1997 May 19;159(21):3134-9.

引用本文的文献

1
Tumor Integrin-Targeted Glucose Oxidase Enzyme Promotes ROS-Mediated Cell Death that Combines with Interferon Alpha Therapy for Tumor Control.肿瘤整合素靶向葡萄糖氧化酶促进活性氧介导的细胞死亡，并与α干扰素疗法联合用于肿瘤控制。
Mol Cancer Ther. 2025 Jan 2;24(1):118-130. doi: 10.1158/1535-7163.MCT-24-0163.
2
Bringing enzymes to the proximity party.让酶参与到邻近反应中。
RSC Chem Biol. 2023 Sep 29;4(12):986-1002. doi: 10.1039/d3cb00084b. eCollection 2023 Nov 29.
3
The past, present, and future of enzyme-based therapies.基于酶的疗法的过去、现在和未来。
Drug Discov Today. 2022 Jan;27(1):117-133. doi: 10.1016/j.drudis.2021.09.004. Epub 2021 Sep 16.
4
Bluetongue Virus Particles as Nanoreactors for Enzyme Delivery and Cancer Therapy.蓝舌病毒颗粒作为酶传递和癌症治疗的纳米反应器。
Mol Pharm. 2021 Mar 1;18(3):1150-1156. doi: 10.1021/acs.molpharmaceut.0c01053. Epub 2021 Feb 10.
5
A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours.一项针对晚期结直肠癌或其他产生癌胚抗原（CEA）肿瘤患者的抗体导向酶前药疗法（ADEPT）的I期试验。
Br J Cancer. 2002 Sep 9;87(6):600-7. doi: 10.1038/sj.bjc.6600517.
6
A fully human anti-Ep-CAM scFv-beta-glucuronidase fusion protein for selective chemotherapy with a glucuronide prodrug.
Br J Cancer. 2002 Mar 4;86(5):811-8. doi: 10.1038/sj.bjc.6600143.
7
In vivo activity in a catalytic antibody-prodrug system: Antibody catalyzed etoposide prodrug activation for selective chemotherapy.催化抗体-前药系统的体内活性：抗体催化依托泊苷前药活化用于选择性化疗。
Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7528-33. doi: 10.1073/pnas.131187998. Epub 2001 Jun 12.